| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Metformin hydrochloride 1 g prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| pioglitazon 15 mg + metformin 1 g, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| trandolapril 1 mg + verapamilhydroklorid 240 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Theophylline 300 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| metoprololsuccinat 25 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| verapamilhydroklorid 400 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| disopyramidfosfat 100 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| vattenfritt teofyllin 600 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| orfenadrincitrat 100 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Oxycodone hydrochloride 40 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| nifedipin 90 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| kinidinsulfat 300 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| oxikodonhydroklorid 160 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| järn(II)glycinsulfat 562,5 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| metoprololsuccinat 50 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely felodipine 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Tramadol hydrochloride 400 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Mirabegron 50 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| metronidazol 750 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| metamfetaminhydroklorid 10 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Isosorbide mononitrate 40 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Sodium valproate 500 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| guajfenesin 600 mg + pseudoefedrin 60 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| prokainamidhydroklorid 250 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nicotinic acid 750 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| klorfenaminmaleat 8 mg + metskopolaminnitrat 2,5 mg + pseudoefedrinhydroklorid 120 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| bupropionhydroklorid 100 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Fesoterodine fumarate 8 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Morphine sulfate 100 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| bupropionhydroklorid 300 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| bupropionhydroklorid 200 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| guajfenesin 1 200 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Fluvastatin (as fluvastatin sodium) 80 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| diltiazem 180 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| takrolimus 750 mikrogram, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| divalproexnatrium 500 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nifedipine 30 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| fexofenadinhydroklorid 60 mg + pseudoefedrinhydroklorid 120 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Metoclopramide hydrochloride 15 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| diltiazem 300 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Felodipine 5 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nifedipine 40 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| järn(II)sulfat 325 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| fexofenadinhydroklorid 180 mg + pseudoefedrinhydroklorid 240 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nisoldipine 30 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Diclofenac sodium 75 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| isradipin 5 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| niacin 375 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| amoxicillin, vattenfritt (som amoxicillin) 775 milligram, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Nevirapine 50 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| fostemsavir 600 mg, depåtablett | Has manufactured dose form | False | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Ranolazine 375 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Aminophylline hydrate 225 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Biperiden hydrochloride 4 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Venlafaxine (as venlafaxine hydrochloride) 37.5 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Venlafaxine (as venlafaxine hydrochloride) 225 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Budesonide 9 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Quetiapine (as quetiapine fumarate) 50 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Quetiapine (as quetiapine fumarate) 150 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  | 
| Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet | Has manufactured dose form | True | Prolonged-release oral tablet | Inferred relationship | Some |  |